<!DOCTYPE html>
<html>
<head>
    <title>In&#xAD;dian pharma firm to make Rus&#xAD;sia&#x2019;s Sput&#xAD;nik V vac&#xAD;cine - PressReader</title>
    <meta name="description" content="">
    <meta content="magazines, newspapers, digital news, reading, news, breaking news, newspaper online" name="keywords">
    <meta name="Robots" content="NOARCHIVE,NOODP">
    <meta charset="UTF-8">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    
    <link rel="canonical" href="/singapore/the-straits-times/20201128/281805696487788" />


    <style>
        li {
            margin: 1em 0;
        }
        img {
            max-width: 100%;
        }
        p, h1, h2, h3 {
            max-width: 100%;
        }
    </style>
</head>
<body>
    <div>
        

<article>
    <h1>In&#xAD;dian pharma firm to make Rus&#xAD;sia&#x2019;s Sput&#xAD;nik V vac&#xAD;cine</h1>
    <h2></h2>
    <section>
        <a href="/singapore/the-straits-times/textview" title="The Straits Times">The Straits Times</a>
        - <a href="/singapore/the-straits-times/20201128/textview" title="The Straits Times - 2020-11-28"><time>2020-11-28</time></a>
        - <span>WORLD</span>
        - <span role="byline"></span>
    </section>

    <p>•</p>
    <p>MOSCOW In­dian phar­ma­ceu­ti­cal com­pany Hetero will man­u­fac­ture more than 100 mil­lion doses of the Rus­sian Sput­nik V Covid-19 vac­cine per year un­der the terms of a deal un­veiled yes­ter­day be­tween it and Rus­sia’s RDIF sov­er­eign wealth fund.</p>
    <p>The move, which RDIF cast as an­other step in its ef­forts to scale up in­ter­na­tional manufactur­ing of its flag­ship vac­cine, will see Hetero be­gin pro­duc­tion in India at the start of next year, ac­cord­ing to a joint state­ment on the Sput­nik V Twit­ter ac­count.</p>
    <p>The state­ment said Phase II-III clin­i­cal tri­als were still un­der way in India, which with a pop­u­la­tion of more than 1.3 bil­lion is the sec­ond-most pop­u­lated coun­try in the world after China.</p>
    <p>Al­though the Rus­sian au­thor­i­ties gave Sput­nik V their reg­u­la­tory ap­proval un­der an ac­cel­er­ated pro­ce­dure in Au­gust, tri­als in Rus­sia, de­signed to as­sess its safety and efficacy, are also on­go­ing.</p>
    <p>“While we look for­ward to the clin­i­cal trial re­sults in India, we be­lieve that manufactur­ing the prod­uct lo­cally is cru­cial to enable swift ac­cess to pa­tients,” said Hetero’s direc­tor of in­ter­na­tional mar­ket­ing B. Mu­rali Kr­ishna Reddy.</p>
    <p>India’s tally of Covid-19 in­fec­tions stands at 9.27 mil­lion, the sec­ond-high­est in the world after the United States, with more than 135,000 deaths.</p>
    <p>An­other In­dian drug maker, Dr Reddy’s Lab­o­ra­to­ries, is con­duct­ing clin­i­cal tri­als of Sput­nik V, and has said it ex­pects late-stage tri­als to be com­pleted by March.</p>
    <p>RDIF head Kir­ill Dmitriev said ear­lier this week that Moscow and its for­eign part­ners had the ca­pac­ity to make more than a bil­lion doses of Sput­nik V starting next year – enough to vac­ci­nate more than 500 mil­lion peo­ple – and that it would cost less than US$20 (S$27) per per­son on in­ter­na­tional mar­kets.</p>


</article>

<section>
    <h3><a href="/catalog/language/english">Newspapers in English</a></h3>
    <h3><a href="/catalog/country/singapore">Newspapers from Singapore</a></h3>
</section>

    </div>
    
    <p><a href="http://www.pressreader.com">© PressReader. All rights reserved.</a></p>

        <script>
            (function (i, s, o, g, r, a, m) {
                i['GoogleAnalyticsObject'] = r; i[r] = i[r] || function () {
                    (i[r].q = i[r].q || []).push(arguments);
                }, i[r].l = 1 * new Date();
                a = s.createElement(o), m = s.getElementsByTagName(o)[0]; a.async = 1; a.src = g;
                m.parentNode.insertBefore(a, m);
            })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
        </script>
        <script>
            ga('create', 'UA-44408245-1');
            ga('send', 'pageView');
        </script>
</body>
</html>
